Directors

Edward Mulhare is Chairman of the Board, having joined the Board in April 1994. He has served as the chairman of the board of SenTech EAS Corporation since May 1994, and over the past ten years has served as a director of fifteen companies including Aldila Inc., Truck Components, Inc., Pan American Diamond Co., McGraw Industries, Inc., and American Silver Co. He served as the chairman of the board and chief executive officer of Merrill Lynch Interfunding, Inc., which managed a $1.6 billion leveraged acquisition portfolio. In addition, he has served as executive vice president of Republic National Bank of New York and vice president of Prudential Insurance Company.

Thomas A. Nicolette is President since February 2007 and Chief Executive Officer effective April 2008. Mr. Nicolette has been a member of the Board since May 2006. Since 2000 he has served as principle of Nicolette Consulting Group Limited. In that role, Mr. Nicolette has been an officer and/or director of companies in the USA, Canada, Mexico, UK, France and Germany. Prior, he has served as Chief Executive Officer of several public companies. The largest, KNOGO Corporation, was a NYSE listed multinational company with subsidiaries and manufacturing facilities in 42 countries around the world employing over 4,000 people. KNOGO, recognized as the founder of the Electronic Article Surveillance (EAS) antishoplifting industry, was sold to Sensormatic Electronics in 1994 and is now part of Tyco International's ADT Security. Mr. Nicolette is a graduate of Michigan State University School of Criminal Justice.

Raymond F. Akers Jr., Ph.D. is Executive Vice Chairman and a member of the Board. Dr. Akers co-founded the Company in 1989. He has over 17 years of experience in the diagnostics industry having co-founded Drug Screening Systems, Inc., a publicly listed company, in 1987 and Akers Medical Technology Inc. in 1984. He was chief executive officer and vice president of research and development of Drug Screening Systems, Inc. until the sale of the company in 1989 and served as president and chief executive officer of Akers Medical Technology Inc. until 1987. He holds a Ph.D. in Neurochemistry from Northwestern University. Dr. Akers is the inventor of PIFA.

Daniel Seckinger, MD is a Non-Executive Director, having joined the Board in February 1994. He had been elected to The College of American Pathologists Board of Governors and served for four years as Chairman of the Council on Scientific Affairs, followed by two years as the President of The College. He is currently the Past President of the American Registry of Pathology. Dr. Seckinger served as Chief of Pathology and Director of Laboratories at Cedars Medical Center for thirty years and presently is Clinical Professor in the Department of Pathology at the University of Miami School of Medicine. He was elected to the American Medical Association House of Delegates and served for nine years followed by two years as the Association's Senior Vice President.

Charles Spencer Bunker is a Non-Executive Director, having joined the Board in October 2008.  He is a Chartered Accountant with over 25 years of experience as a corporate financier. As a founding member of Kerburn Rose, an independent corporate finance house, he has made a significant contribution to the value enhancement of a number of businesses across a range of sectors. He is a former Chairman of the Board of Governors of the European Business School and of Regent's College, the UK based American college. He has a personal interest in the healthcare sector in which ABI is involved, having served as a nonexecutive Director of both a leading NHS Trust and Health Authority.

 

Committees

Audit committee
The audit committee, which meets at least twice each year, comprises Charles Bunker (chairman), Dan Seckinger, MD, and Ed Mulhare . The audit committee is responsible for ensuring that the financial performance of the Company is properly monitored and reported on. It meets with the auditors who are formally invited to attend each meeting without the executive directors being present, and reviews reports relating to accounts and internal control systems.

The committee operates within specific terms of reference which include; considering the appointment of external auditors; reviewing the effectiveness of financial reporting and internal control procedures; monitoring the integrity of the financial statements of the Company, and any significant financial reporting judgments contained therein; and reviewing the independence and objectivity of the external auditors.

Remuneration committee
The Company’s Remuneration Committee comprises Dan Seckinger, MD (chairman), Ed Mulhare, and Charles Bunker. The principle purpose of the Committee is to agree the directors' salary increases, annual bonuses and any changes in benefits. It also agrees share options granted to the directors. For the purpose of reaching appropriate decisions the Committee may refer to relevant sources of information.

Senior Executives

Robert J. Paratore is Chief Financial Officer effective April 2008. He joined the Company in 2001 as the Assistant Controller. Mr. Paratore, a graduate of the University of Delaware with a BS in Accounting, has extensive experience in general and cost accounting.

Leroy J. Meyers, Jr., Vice President of Operations, having joined the Company in July 2002. During his career, Mr. Meyers served in similar positions in medical product companies for more than 25 years. Mr. Meyers holds a BS in Biology from Rutgers University.

Patrice Laterra McMorrow, Vice President of Business Development, joined the Company in June 2004. Ms. McMorrow has 20 years of sales and marketing experience in the pharmaceutical, ophthalmic eyewear and fashion industries. Competencies include sales operations, distribution management, and strategic and tactical planning. She holds an MBA in Marketing from Seton Hall University.

Articles of Incorporation

Click here to download a PDF version of the Articles of Incorporation.